v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss $ (3,788) $ (3,023) $ (2,794) $ (3,705) $ (6,811) $ (6,499)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and Amortization         571 377  
Abandonment and expiration of patents and trademark rights         24 615  
Equity-based compensation         60  
Gain on sale of marketable investments         (18)  
Change in fair value of warrants     468  
Loss on issuance of warrants         32  
Change in assets and liabilities:              
Prepaid expenses and other assets         (121) 770  
Lease liability         (120) (78)  
Accounts payable and Accrued Expenses         (1,359) 881  
Other receivables         7  
Net cash used in operating activities         (7,309) (3,892)  
Cash flows from investing activities:              
Proceeds from sale of marketable investments         4 2,026  
Purchase of marketable investments         (6) (91)  
Purchase of patent and trademark rights         (147) (283)  
Net cash (used in) provided by investing activities         (149) 1,652  
Cash flows from financing activities:              
Proceeds from sale of stock, net of issuance costs         2,538 765  
Proceeds from note payable, net of issuance costs         250  
Proceeds from warrant exercise         5,733  
Repayment of debt obligation         (821)  
Proceeds from Registered Direct Offerings         5,293  
Proceeds from Rights Offering         1,630  
Net cash provided by financing activities         14,373 1,015  
Net increase (decrease) in cash and cash equivalents         6,915 (1,225)  
Cash and cash equivalents at beginning of period   $ 2,985   $ 1,701 2,985 1,701 $ 1,701
Cash and cash equivalents at end of period $ 9,900   $ 476   9,900 476 $ 2,985
Supplemental disclosures of non-cash investing and financing cash flow information:              
Unrealized gain on marketable investments         85  
Repayment of debt obligation with shares         $ 400 $ 421